COMMUNIQUÉS West-GlobeNewswire

Catalyst Biosciences Joins the Russell 2000® Index
25/06/2018
SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications [...]
Biomerica Announces First Patient Enrollment in Clinical Study for New Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy
25/06/2018
Diagnostic Guided Therapy (DGT) is designed to identify patient specific foods, that when removed, may alleviate an individual's IBS symptoms Approximately 45 million Americans suffer from IBS 1 Studies being conducted [...]
GTX Corp Announces Strategic Plan to Up-List to the OTCQB Venture Exchange
25/06/2018
LOS ANGELES, June 25, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO) (“the Company”) , a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology, announced today it has [...]
Avid Bioservices Added to Russell 3000® Index and Russell 2000® Index
25/06/2018
TUSTIN, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Nuvectra Added to the Russell 2000® Index
25/06/2018
PLANO, Texas, June 25, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it was added to the Russell 2000 ® Index when Russell Investments [...]
Endocyte to Join the Russell 3000® Index
25/06/2018
WEST LAFAYETTE, Ind., June 25, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that its common stock [...]
Savara Joins Russell 3000® Index
25/06/2018
AUSTIN, Texas, June 25, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (NASDAQ:SVRA), an orphan lung disease company, announced today that the company has been added to the broad-market Russell 3000 Index. “In the little more [...]
BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue
25/06/2018
Pioneering biotech company reaches significant milestone well ahead of 6-8 month development time, successfully 3D bioprinting a human cardiac patch, as it seeks to produce full human hearts viable for transplant [...]
Atara Biotherapeutics Opens State-of-the-Art Operations and Manufacturing Facility to Support Robust Off-the-Shelf T-Cell Immunotherapy Pipeline
25/06/2018
SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
ContraVir Pharmaceuticals Initiates Dosing of CRV431 in First In-Human Trial
25/06/2018
Corporate, Business and Clinical Update Conference Call and Live Audio Webcast Scheduled for Today at 4:30 p.m. ET EDISON, N.J., June 25, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a [...]
Additional Positive Afrezza® Clinical Data from STAT Study To Be Presented at ADA 78th Scientific Sessions
25/06/2018
Oral presentation (348-OR) at 5:00 pm today Afrezza provides greater improvement in post-prandial glucose control than insulin aspart WESTLAKE VILLAGE, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation ( [...]
Cocrystal Pharma Announces Inclusion in Russell Microcap® Index
25/06/2018
ATLANTA, GA and BOTHELL, WA, June 25, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral [...]
CymaBay Therapeutics Added to the Russell 3000® and Russell 2000® Indexes
25/06/2018
NEWARK, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet [...]
AMITA Health Selects R1 RCM for End-to-End Revenue Cycle Management
25/06/2018
Presence Health Agreement Signed CHICAGO, June 25, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today [...]
CLS Holdings USA Announces Closing of Oversubscribed C$13.0 Million Private Placement
25/06/2018
TORONTO and LAS VEGAS, June 25, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB:CLSH) “CLS,” a development stage diversified cannabis company operating as Cannabis Life Sciences, is pleased to announce the [...]
PDC Hosts 8th Annual Brady Walk for Community to Raise Funds for Local Charities in Southern California
25/06/2018
Proceeds will be Donated to Michael Hoefflin Foundation and Speak Out Against Bullying VALENCIA, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- PDC , a global leader of innovative identification solutions, will host the 8 th [...]
PositiveID Subsidiary Chief Science Officer Joins Cambridge Healthtech Institute’s 26th Biodetection Technologies: Biothreat and Pathogen Detection
25/06/2018
PositiveID ExcitePCR subsidiary develops FireflyDX products for rapid, portable biothreat detection, a key to containment DELRAY BEACH, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “ [...]
Tyme Technologies, Inc. Set to Join Russell 3000® Index
25/06/2018
NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced it is set to join the Russell 3000 [...]
Vital Therapies Joins the Russell 3000 Index®
25/06/2018
SAN DIEGO, June 25, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD ® , a cell-based therapy targeting the treatment of acute forms of liver failure, announced it [...]

Pages